Sep 2013

Home >> Clinical Trials News Archive >> 2013 >> Sep 2013
Q-Trials team is proud to announce that we have obtained MoH Approval for a Gene Therapy Study, within several weeks! This is an unprecedented achievement as far as we know, allowing a speedy initiation of a gene therapy study. We owe a great deal to the MoH Clinical Trials department for working relentlessly with our team towards this goal! 

TAU and Technion Connect With China
 The life sciences figure prominently in major new collaborations between two Israeli universities and China. Li Ka Shing, one of the wealthiest people in the world, is giving $130 million to the Technion to build a research center in China, a joint project between the Technion and Shantou University, located in Guangdong Province.
Outlook brighter for Israeli VC funds, but don’t expect the go-go years. Israeli high-tech appears to be booming, but megadeals like the $1 billion sale of Waze to Google and the approaching initial public offering by Outbrain conceal one of the industry's biggest problems: the meager capital being raised by Israeli venture capital funds. So Pitango Venture Capital's closing of its sixth fund at $270 million this week brightened the atmosphere.
The 2nd Annual International Partnering of the Israeli BioMedTech Industry Life Sciences Israel 2013 will be held on 16-17 October 2013 in Dan Panorama Hotel, Tel Aviv.
Commercializing Innovation under the Health Reform. The IATI is happy to host Susan Berson, a senior health law specialist and Managing Member of Mintz Levin’s DC office, for a private round table discussion on Tuesday, October 8, in Herzliya Pituach.
BrainTech Israel 2013 -Israel’s first international brain technology conference, to be held in Tel Aviv on October 14-15, 2013, hosted by Israel Brain Technologies (IBT). IBT is a non-profit organization, inspired by the vision of Israeli President Shimon Peres, to promote Israel’s neurotechnology innovation hub.